Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.

Blackweek’s inaugural three-day conference featured several health-focused panels discussing health equity and more inclusive ...

This week, Johnson & Johnson JNJ began the third-quarter earnings season for the drug and biotech sector. The FDA granted ...

Deal volumes for pharmaceutical deals were lower in 2023 than they were 10 years ago and have been lower, on average, than ...

Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

The underlying issue for pharma companies using AI lies in the quality of the inputs and how AI models are used.

Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...

Astellas Pharma's drug Vyloy was approved for treatment of advanced gastric and gastroesophageal junction cancer by the Food and Drug Administration.

The evolution of Pharma 4.0 integrates advanced technologies, transforming drug development and manufacturing with improved ...

Scilex Pharma may soon flee the nest after its parent company Scilex Holding’s board of directors granted permission to ...

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion. Read more on ...

Benchmark NSE Nifty50 index was down 23.9 points at 24725.95, while the BSE Sensex was down 143.82 points at 80862.79. Among ...